A bidirectional relationship exists between having a sense of meaning in life and behavioral health issues such as anxiety, ...

KLANG: Depression, linked to menopause or hormonal imbalance, can emerge in elderly women even after a decade or more after they have stopped menstruating. However, many remain oblivious as to why ...

While genetics and life events can contribute to depression, a new study from Colorado State University has found that social isolation is one of the biggest risk factors, especially for older adults.

Both major and minor depression are reported in 13% of community dwelling older adults, 24% of older medical outpatients and 43% of both acute care and nursing home dwelling older adults.

Researchers found that the rate difference of depression was 3.48 per 1000 person-years between GLP-1 RA users and SGLT-2i users. HealthDay News — For older adults with type 2 diabetes (T2D ...

Scientists at Karolinska Institutet have found that duloxetine, a commonly used antidepressant, may also have benefits for memory and thinking abilities in older adults. Their findings, published in ...

and up to 75% of seniors experience symptoms of insomnia. In addition to being frustrating, insomnia can increase your risk of heart disease, dementia, anxiety and depression — and it can also ...

A group of more than 25 seniors listened to a presentation by Cherie Castellano, founder and owner of VolunPEER, a Roseland based non-profit that aims to “get, give, ...

(HealthDay News) — For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a modestly lower risk for depression compared with ...

More information: Huilin Tang et al, Glucagon-Like Peptide-1 Receptor Agonists and Risk for Depression in Older Adults With Type 2 Diabetes, Annals of Internal Medicine (2025). DOI: 10.7326/ANNALS ...

Modestly lower risk for depression seen compared with DPP-4i use, but not compared with SGLT-2i use. (HealthDay News) — For older adults with type 2 diabetes (T2D), use of glucagon-like peptide ...